Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 6Phase NA 4Phase 4 2Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Cancer Pain 2Pain 1Opioid-Related Disorders 1Lymphoma, Follicular 1

Interventions

Methadone 3Cryotherapy 3Cryosurgery 3Oxycodone 2trimebutine 3-thiocarbamoylbenzenesulfonate 1piperine 1Sodium Bicarbonate 1Rosuvastatin Calcium 1Radiotherapy 1Radiation 1Propofol 1Photochemotherapy 1Olive Oil 1Morphine 1Massage 1Lidocaine 1Laser Therapy 1Injections 1Hydromorphone 1Gabapentin 1Electroencephalography 1Dronabinol 1Dexamethasone 1Curcumin 1Control Groups 1Calcium Dobesilate 1Analgesia, Epidural 1Amidines 1Acupuncture Therapy 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pain × Morphine × Clear all
NCT00125684 2012-01-19

Bioavailability and Effectiveness of Transdermally Administered Morphine

AHS Cancer Control Alberta

Phase 1 Completed
6 enrolled

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡